Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Shares Outstanding (2016 - 2025)

Neuronetics (STIM) has disclosed Shares Outstanding for 10 consecutive years, with $69.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 23.88% to $69.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.0 million through Dec 2025, up 23.88% year-over-year, with the annual reading at $69.0 million for FY2025, 23.88% up from the prior year.
  • Shares Outstanding for Q4 2025 was $69.0 million at Neuronetics, up from $68.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $69.0 million in Q4 2025, with the low at $25.8 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $37.2 million, with a median of $28.9 million recorded in 2023.
  • The sharpest move saw Shares Outstanding rose 2.63% in 2022, then soared 125.76% in 2025.
  • Over 5 years, Shares Outstanding stood at $26.4 million in 2021, then rose by 3.31% to $27.3 million in 2022, then increased by 6.69% to $29.1 million in 2023, then skyrocketed by 91.46% to $55.7 million in 2024, then rose by 23.88% to $69.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $69.0 million, $68.4 million, and $66.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.